Delivery Order SPE2DR25D1110-SPE2DR26F13PM
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $6,497.32 to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injectors, with an ultimate completion date of January 22, 2026. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a $3,248.66 delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Benlysta 200 mg/mL auto-injector. This is a firm fixed price, competitively awarded contract with an ultimate completion date of December 9, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a $3,082.67 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of BENLYSTA 200 mg/mL auto-injector medication. This non-set-aside, competitively awarded contract reflects a firm fixed price delivery order with an ultimate completion date of August 18, 2025. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order valued at $6,973.34 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/mL auto-injector on January 2, 2026, with a completion date of January 26, 2026. This non-competitive, firm fixed-price delivery order represents a single pharmaceutical procurement supporting federal medical supply requirements. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order...
- The Defense Logistics Agency awarded a $27,893.36 delivery order to AmerisourceBergen Drug Corp on January 9, 2026, for the supply of Benlysta 200 mg/ml auto-injector units. This is a firm fixed-price, competitively awarded contract with an ultimate completion date of February 2, 2026. The pharmaceutical product will be delivered to the prime contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- The Defense Logistics Agency awarded a $6,165.34 delivery order to AmerisourceBergen Drug Corp for BENLYSTA 200 mg/mL auto-injector on July 21, 2025, with completion scheduled for August 11, 2025. This is a firm fixed price, non-set-aside contract utilizing competitively awarded pricing. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Benlysta 200 mg/mL auto-injector, valued at $6,165.34. This is a firm fixed price, non-competitive delivery order with an ultimate completion date of September 12, 2025. The order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through...
- The Defense Logistics Agency awarded a delivery order valued at $3,248.66 to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Benlysta 200 mg/ml auto-injector units. This competitively awarded, firm fixed-price contract is scheduled for completion by December 19, 2025, and carries no set-aside designation. The award will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $3,248.66 to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector on December 9, 2025, with completion expected by December 31, 2025. This competitively awarded, firm fixed-price delivery order requires performance at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $3,082.67 delivery order contract to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Benlysta 200 mg/ml auto-injector medication. The contract, which is not set-aside and operates under firm fixed pricing, is scheduled for completion by August 4, 2025. AmerisourceBergen Drug Corp will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where the company serves as a major pharmaceutical distributor...
- SPE2DR25D1110Indefinite Delivery Contract
- SPE2DR25D1110-SPE2DR26F13PMDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,973.34 to AmerisourceBergen Drug Corp on January 13, 2026, for the supply of BENLYSTA 200 MG/ML auto-injector pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of February 4, 2026, and carries no set-aside designation, indicating it was competitively awarded. Performance will be executed at the vendor's location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under a larger Indefinite Delivery Contract with the DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as the comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a vast range of pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. (which conducts business as AmerisourceBergen), is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The parent company holds the primary $999,999,999.00 indefinite delivery contract with DLA through December 31, 2031, encompassing specialty medications, brand-name and generic drugs, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. Through this contract vehicle and related delivery orders, the company supplies essential pharmaceutical products to support the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.0k | 1/12/26 |